ES2184122T3 - Vacuna polinucleotidica bovina por via intradermica. - Google Patents

Vacuna polinucleotidica bovina por via intradermica.

Info

Publication number
ES2184122T3
ES2184122T3 ES97934575T ES97934575T ES2184122T3 ES 2184122 T3 ES2184122 T3 ES 2184122T3 ES 97934575 T ES97934575 T ES 97934575T ES 97934575 T ES97934575 T ES 97934575T ES 2184122 T3 ES2184122 T3 ES 2184122T3
Authority
ES
Spain
Prior art keywords
bovine
administration
polinucleotidic
vaccine
intradermica
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97934575T
Other languages
English (en)
Inventor
Franciscus Antonius Rijsewijk
Remco Siebren Schrijver
Oirschot Johannes Theodoru Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ID DLO INST OF ANIMAL SCIENCE
Boehringer Ingelheim Animal Health France SAS
Original Assignee
ID DLO INST OF ANIMAL SCIENCE
Merial SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ID DLO INST OF ANIMAL SCIENCE, Merial SAS filed Critical ID DLO INST OF ANIMAL SCIENCE
Application granted granted Critical
Publication of ES2184122T3 publication Critical patent/ES2184122T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265—Infectious rhinotracheitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16741—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18541—Use of virus, viral particle or viral elements as a vector
    • C12N2760/18543—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Abstract

LA FORMULA DE VACUNA BOVINA POLINUCLEOTIDICA COMPRENDE UNA CANTIDAD EFICAZ POR VIA INTRADERMICA DE UN PLASMIDO QUE ASOCIA UNA SECUENCIA DE ADN QUE CODIFICA UN INMUNOGENO DE UNA AGENTE PATOGENO BOVINO Y UN PROMOTOR QUE PERMITE LA EXPRESION DE ESTE INMUNOGENO IN VIVO EN CELULAS DE LA PIEL, ADAPTANDOSE ESTA FORMULA DE VACUNA A LA ADMINISTRACION INTRADERMICA POR UN APARATO DE ADMINISTRACION POR CHORRO LIQUIDO. LA INSTALACION PORTATIL DE VACUNACION BOVINA COMPRENDE UN APARATO DE ADMINISTRACION POR CHORRO LIQUIDO Y UN FRASCO ADAPTADO QUE INCLUYE VARIAS DOSIS DE TAL FORMULA DE VACUNA, ESTANDO EL APARATO DE ADMINISTRACION DISEÑADO PARA SUMINISTRAR UNA DOSIS DE FORMULA DE VACUNA DE MANERA INTRADERMICA.
ES97934575T 1996-07-19 1997-07-16 Vacuna polinucleotidica bovina por via intradermica. Expired - Lifetime ES2184122T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9609402A FR2751228B1 (fr) 1996-07-19 1996-07-19 Vaccin polynucleotidique bovin pour voie intradermique

Publications (1)

Publication Number Publication Date
ES2184122T3 true ES2184122T3 (es) 2003-04-01

Family

ID=9494496

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97934575T Expired - Lifetime ES2184122T3 (es) 1996-07-19 1997-07-16 Vacuna polinucleotidica bovina por via intradermica.

Country Status (23)

Country Link
US (2) US6451770B1 (es)
EP (1) EP0918540B1 (es)
JP (1) JP2000515522A (es)
AP (1) AP9701045A0 (es)
AR (1) AR007863A1 (es)
AT (1) ATE224732T1 (es)
AU (1) AU722878B2 (es)
BR (1) BR9710498A (es)
CA (1) CA2261334C (es)
CO (1) CO4700344A1 (es)
CZ (1) CZ298216B6 (es)
DE (1) DE69715879T2 (es)
ES (1) ES2184122T3 (es)
FR (1) FR2751228B1 (es)
HU (1) HU224833B1 (es)
ID (1) ID19427A (es)
IL (1) IL127914A (es)
MA (1) MA24271A1 (es)
MX (1) MXPA99000684A (es)
NZ (1) NZ333752A (es)
PL (1) PL189184B1 (es)
WO (1) WO1998003196A1 (es)
ZA (1) ZA976285B (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7294338B2 (en) * 1996-07-19 2007-11-13 Merial Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
FR2751228B1 (fr) * 1996-07-19 1998-11-20 Rhone Merieux Vaccin polynucleotidique bovin pour voie intradermique
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
FR2804028B1 (fr) * 2000-01-21 2004-06-04 Merial Sas Vaccins adn ameliores pour animaux de rente
US7078388B2 (en) * 2000-01-21 2006-07-18 Merial DNA vaccines for farm animals, in particular bovines and porcines
US7906311B2 (en) 2002-03-20 2011-03-15 Merial Limited Cotton rat lung cells for virus culture
EP2390352A1 (en) 2003-03-18 2011-11-30 Quantum Genetics Ireland Limited Systems and methods for improving protein and milk production of dairy herds
US7468273B2 (en) 2003-05-01 2008-12-23 Meial Limited Canine GHRH gene, polypeptides and methods of use
CA2545886A1 (en) 2003-11-13 2005-06-02 University Of Georgia Research Foundation, Inc. Methods of characterizing infectious bursal disease virus
AU2005244673B2 (en) 2004-02-19 2009-12-10 The Governors Of The University Of Alberta Leptin promoter polymorphisms and uses thereof
RS52705B (en) * 2004-06-04 2013-08-30 Merial Limited Administration of FeLV Vaccine Without Needle
WO2006115843A2 (en) 2005-04-25 2006-11-02 Merial Limited Nipah virus vaccines
US8591457B2 (en) 2005-08-10 2013-11-26 Alza Corporation Method for making a needle-free jet injection drug delivery device
US20080241184A1 (en) 2005-08-25 2008-10-02 Jules Maarten Minke Canine influenza vaccines
EP1951751B1 (en) 2005-11-14 2017-11-01 Merial, Inc. Gene therapy for renal failure
US7771995B2 (en) 2005-11-14 2010-08-10 Merial Limited Plasmid encoding human BMP-7
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
CA2684923C (en) 2007-05-02 2015-01-06 Merial Limited Dna plasmids having improved expression and stability
US20080274137A1 (en) * 2007-05-02 2008-11-06 Jean Christophe Francis Audonnet DNA plasmids having improved expression and stability
CN102271704A (zh) 2008-11-28 2011-12-07 梅里亚有限公司 重组禽流感疫苗及其用途
EP2414386B1 (en) 2009-04-03 2016-01-27 Merial Limited Newcastle disease virus vectored avian vaccines
CA2785653C (en) 2009-12-28 2018-05-01 Merial Limited Recombinant ndv antigen and uses thereof
US20130197612A1 (en) 2010-02-26 2013-08-01 Jack W. Lasersohn Electromagnetic Radiation Therapy
BR112012023852B1 (pt) 2010-03-12 2020-11-10 Biolex Therapeutics vacinas recombinantes do vírus da língua azul e usos das mesmas
BR112013007486B1 (pt) 2010-08-31 2020-01-28 Merial Ltd composição, vetor recombinante de ndv e uso da referida composição
WO2012090073A2 (en) 2010-12-30 2012-07-05 The Netherlands Cancer Institute Methods and compositions for predicting chemotherapy sensitivity
AU2012240246A1 (en) 2011-04-04 2013-05-09 Netherlands Cancer Institute Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
US20140296248A1 (en) 2011-04-04 2014-10-02 Stichting het Nederlands Kanker Instiuut-Antoni van Leeuwenhoek ziekenhuis Methods and compositions for predicting resistance to anticancer treatment
AU2012245395A1 (en) 2011-04-20 2013-11-14 Merial, Inc. Adjuvanted rabies vaccine with improved viscosity profile
AP2013007180A0 (en) 2011-04-25 2013-10-31 Advanced Bioscience Lab Inc Truncated HIV envelope proteins (ENV), methods andcompositions related thereto
ES2764079T3 (es) 2011-05-27 2020-06-02 Boehringer Ingelheim Animal Health Usa Inc Vacunas genéticas contra el virus Hendra y el virus Nipah
CA2837375C (en) 2011-06-01 2019-07-16 Merial Limited Needle-free administration of prrsv vaccines
JP6041361B2 (ja) 2011-08-12 2016-12-07 メリアル インコーポレイテッド 生物学的製品、特にはワクチンの真空保存
WO2013093629A2 (en) 2011-12-20 2013-06-27 Netherlands Cancer Institute Modular vaccines, methods and compositions related thereto
NZ628270A (en) 2012-02-14 2016-09-30 Merial Inc Recombinant poxviral vectors expressing both rabies and ox40 proteins, and vaccines made therefrom
JP6149240B2 (ja) 2012-02-14 2017-06-21 メリアル インコーポレイテッド ロタウイルスサブユニットワクチン並びにその製造及び使用方法
WO2013138776A1 (en) 2012-03-16 2013-09-19 Merial Limited Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g
ES2664069T3 (es) 2012-06-13 2018-04-18 Merial, Inc. Vacunas contra BTV y AHSV de genoma reordenado
WO2014164697A1 (en) 2013-03-12 2014-10-09 Merial Limited Reverse genetics schmallenberg virus vaccine compositions, and methods of use thereof
EP3215188A1 (en) 2014-11-03 2017-09-13 Merial, Inc. Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
AU2016282772B2 (en) 2015-06-23 2019-09-05 Boehringer Ingelheim Animal Health USA Inc. PRRSV minor protein-containing recombinant viral vectors and methods of making and use thereof
WO2017031120A1 (en) 2015-08-20 2017-02-23 Merial, Inc. Fcv recombinant vaccines and uses thereof
AU2016332037B2 (en) 2015-09-29 2019-06-27 Boehringer Ingelheim Animal Health USA Inc. Canine parvovirus (CPV) virus-like particle (VLP) vaccines and uses thereof
EP3380119B1 (en) 2015-11-23 2021-08-25 Boehringer Ingelheim Animal Health USA Inc. Fmdv and e2 fusion proteins and uses thereof
TWI760322B (zh) 2016-01-29 2022-04-11 美商百靈佳殷格翰動物保健美國有限公司 重組腺病毒載體裝載之fmdv疫苗及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2348709A1 (fr) * 1976-04-23 1977-11-18 Pistor Michel Procede de traitement mesotherapique et dispositif d'injection,formant micro-injecteur automatique,en comportant application
FR2652257B1 (fr) * 1989-09-26 1992-11-27 Rhone Merieux Installation portative de vaccination porcine.
WO1992001471A1 (en) * 1990-07-24 1992-02-06 The Uab Research Foundation Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells
GB9118204D0 (en) * 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
US5643578A (en) * 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
ATE197904T1 (de) * 1993-07-31 2000-12-15 Weston Medical Ltd Nadelloser injektor
ES2348013T3 (es) * 1994-01-27 2010-11-26 University Of Massachusetts Medical Center Inmunización por inoculación de una unidad de transcripción de adn.
US5736524A (en) * 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
FR2751228B1 (fr) * 1996-07-19 1998-11-20 Rhone Merieux Vaccin polynucleotidique bovin pour voie intradermique

Also Published As

Publication number Publication date
IL127914A (en) 2001-05-20
US6451770B1 (en) 2002-09-17
CZ10699A3 (cs) 1999-04-14
CZ298216B6 (cs) 2007-07-25
EP0918540B1 (fr) 2002-09-25
CA2261334C (en) 2010-11-16
ZA976285B (en) 1999-01-19
ATE224732T1 (de) 2002-10-15
IL127914A0 (en) 1999-11-30
WO1998003196A1 (fr) 1998-01-29
AU3773297A (en) 1998-02-10
BR9710498A (pt) 2000-01-18
CO4700344A1 (es) 1998-12-29
CA2261334A1 (en) 1998-01-29
FR2751228B1 (fr) 1998-11-20
AR007863A1 (es) 1999-11-24
US20020137716A1 (en) 2002-09-26
PL189184B1 (pl) 2005-07-29
PL331237A1 (en) 1999-07-05
AP9701045A0 (en) 1997-07-31
JP2000515522A (ja) 2000-11-21
HUP9902792A3 (en) 2000-03-28
NZ333752A (en) 2000-06-23
ID19427A (id) 1998-07-09
US6803361B2 (en) 2004-10-12
MXPA99000684A (es) 2006-02-10
MA24271A1 (fr) 1998-04-01
DE69715879T2 (de) 2003-01-23
EP0918540A1 (fr) 1999-06-02
FR2751228A1 (fr) 1998-01-23
AU722878B2 (en) 2000-08-10
DE69715879D1 (de) 2002-10-31
HU224833B1 (en) 2006-03-28
HUP9902792A2 (hu) 1999-12-28

Similar Documents

Publication Publication Date Title
ES2184122T3 (es) Vacuna polinucleotidica bovina por via intradermica.
NO900151L (no) Anordning for kontrollert tilfoersel av et eller flere fordelaktige midler.
AR012939A1 (es) Inhalador.
DK16487A (da) Vacciner til oral indgift
NO933431L (no) Gassholdige kontrastmidler
ES2092306T3 (es) Adyuvante para vacunas.
IT8667329A0 (it) Dispositivo osmotico comprendente mezzi per regolare la durata iniziale di erogazione di un agente medicinale da detto dispositivo
ES2125679T3 (es) Sistema transdermico de administracion simultanea de varios principios activos.
KR900011485A (ko) 리오트로픽 액정에 의해 작동되는 분배 장치
ES2038064B1 (es) Instalacion portatil de vacunacion aviar.
ECSP972184A (es) Vacuna polinucleotidica destinada a bovinos por via intradermica
MX9203735A (es) Una forma de dosis mejorada para suministrar una droga o un agente terapeutico a un ambiente de uso.
ES2159795T3 (es) Dispositivo y metodo de esterilizacion de aire comprimido para uso medico.
ES2115245T3 (es) Vacuna contra la disenteria hemorragica del cerdo y conjunto de vacunacion correspondiente.
FR2652257B1 (fr) Installation portative de vaccination porcine.
UA32800A (uk) Спосіб лікування неспецифічних вагінітів у жінок в постменопаузі
IT216817Z2 (it) Dispositivo linguale ausiliario per apparecchi ortodontici meccano terapeutici.
IT1225034B (it) Dispositivo generatore di ozono per uso medicale